Go to Top

In the Spotlight

Gabriel P. López, Ph.D.

Gabriel P. López, Ph.D. Vice President for Research Professor, Department of Chemical & Biological Engineering Founding Director and Member, Center for Biomedical Engineering The University of New Mexico Eta Diagnostics, Inc. (STC start-up) Pucara Engineering and Logistics, LLC (STC start-up) ieCrowd (STC start-up being spun out) Dr.  López has disclosed 53 inventions to STC, received 34 UNM-affiliated issued U. S. patents, has one pending patent application, one license agreement with …Read More

Walker R. Wharton, Ph.D.

Walker R. Wharton, Ph.D. Research Professor, Department of Pathology Health Sciences Center The University of New Mexico Dr.  Wharton has disclosed eight inventions to STC, received one UNM-affiliated issued U. S. patent, has three pending patent applications for his protocell technologies, and has one license agreement with Oncothyreon for his protocell technology. Drug delivery is one of the most important areas in nanomedicine, which utilizes nanoscale materials and principles as …Read More

Mahmoud R. Taha, Ph.D.

Mahmoud R. Taha, Ph.D. Professor, Regents’ Lecturer and Chair, Department of Civil Engineering Cross Appointments: Department of Mechanical Engineering, Department of Electrical & Computer Engineering, and Center for Biomedical Engineering The University of New Mexico Dr.  Taha has disclosed 18 inventions to STC, received two UNM-affiliated issued U. S. patents, and has seven pending patent applications for his polymer concretes, nanocomposites and composite technologies. Dr. Taha’s polymer concrete technology combines …Read More

Bridget S. Wilson, Ph.D.

Bridget S. Wilson, Ph.D. Professor, Department of Pathology Director, New Mexico Center for Spatiotemporal Modeling of Cell Signaling Health Sciences Center The University of New Mexico Dr. Wilson has disclosed four inventions and has two pending patent applications for her recombinant hypoallergens technology and her therapeutic antibodies technology for targeting pre-BCR B cell precursor in acute lymphoblastic leukemia (pre-B ALL). Dr. Wilson’s recombinant hypoallergens technology uses state-of-the art imaging and …Read More

Andrew P. Shreve, Ph.D.

Andrew P. Shreve, Ph.D. Professor, Department of Chemical & Biological Engineering Director, Center for Biomedical Engineering The University of New Mexico Eta Diagnostics, Inc. (STC start-up) Dr.  Shreve has disclosed five inventions to STC, received one UNM-affiliated issued U. S. patent, has two pending patent applications, and one license agreement with start-up Eta Diagnostics, Inc., for multinode parallel flow cytometry technologies. Dr. Shreve’s overall research focuses on development of optical-based …Read More

Jason T. McConville, Ph.D.

Jason T. McConville, Ph.D. Associate Professor, Department of Pharmaceutical Sciences Health Sciences Center The University of New Mexico Dr. McConville has disclosed five inventions to STC and has three pending patent applications for a wireless medication monitor, an aerosol delivery method for nutraceuticals, and a polymeric coating technology. Even in affluent countries with well-developed healthcare infrastructure, adherence to long-term medication therapy for chronic illness averages only 50 percent.  Medical compliance …Read More

Yuliya V. Kuznetsova, Ph.D.

Yuliya V. Kuznetsova, Ph.D. Research Assistant Professor, Center for High Technology Materials  The University of New Mexico  Armonica Technologies LLC (STC start-up) Dr.  Kuznetsova has disclosed eight inventions to STC, received five UNM-affiliated issued U. S. patents, has six pending patent applications, and an option to license agreement with start-up Armonica Technologies LLC for her nanopore sequencing technology. Imaging interferometric microscopy is a synthetic aperture approach which uses a low …Read More

Robert A. Orlando, Ph.D.

Robert A. Orlando, Ph.D. Associate Professor, Department of Biochemistry & Molecular Biology Health Sciences Center The University of New Mexico Dr.  Orlando has disclosed five inventions to STC, received one UNM-affiliated issued U. S. patent, has one pending patent application for his therapeutic curcumin derivatives technology, and one license agreement with EMD Millipore Corporation for his polyclonal antibodies. Dr. Orlando’s technologies include a novel hepatic receptor that serves as the …Read More

Richard A. Kemp, Ph.D.

Richard A. Kemp, Ph.D. Professor, Department of Chemistry & Chemical Biology The University of New Mexico Principal Member of the Scientific Staff, Sandia National Laboratories Dr. Kemp has disclosed six inventions to STC and has five pending patent applications with UNM and Sandia National Labs for his carbon dioxide and nanomaterials technologies. Dr. Kemp’s carbon dioxide (CO2) sequestering technology is a process for recycling waste CO2 into useful organic products …Read More

Renata Pasqualini, Ph.D.

Renata Pasqualini, Ph.D. Professor, Department of Internal Medicine Chief, Division of Molecular Medicine Health Sciences Center The University of New Mexico Dr. Pasqualini has disclosed three inventions to STC and has three UNM-affiliated pending patent applications for her new therapeutic drugs to treat prostate, lung and breast cancers. In 2014, the National Cancer Institute estimated that there will be 233,000 new cases of prostate cancer in the U.S. and 29,480 …Read More